Toxicity in head and neck cancer: a review of trends and issues

Devita, 1997 Perry, 1992 Haskell CM. Cancer treatment. 4th ed. Philadelphia: W.B. Saunders; 1995. Chabner, 1996 Arbuck SG, Eisenhauer EA, Ivy SP; et al. The revised common toxicity criteria: Version 2. J Natl Cancer Inst Submitted. Trotti, 1997, Toxicity antagonists in cancer therapy, Curr Opin Oncol, 9, 569, 10.1097/00001622-199711000-00013 Cox, 1995, Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) [editorial], Int J Radiat Oncol Biol Phys, 31, 1341, 10.1016/0360-3016(95)00060-C World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva: WHO; Offset publication No.48. 1979. Miller, 1981, Reporting results of cancer treatment, Cancer, 47, 207, 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6 Brundage, 1993, Assessing the reliability of two toxicity scales, J Natl Cancer Inst, 85, 1138, 10.1093/jnci/85.14.1138 Corder, 1984, A decision-analysis methodology for consideration of morbidity factors in clinical decision-making, Am J Clin Oncol, 6, 19, 10.1097/00000421-198402000-00003 Donk, 1995, Patient participation in clinical decision-making for treatment of T3 laryngeal cancer, J Clin Oncol, 13, 2369, 10.1200/JCO.1995.13.9.2369 Casali, 1997, Quality of life assessment and clinical decision-marking, Ann Oncol, 8, 1207, 10.1023/A:1008276901910 Brundage, 1997, Trading treatment toxicity for survival in local advanced non-small cell lung cancer, J Clin Oncol, 15, 330, 10.1200/JCO.1997.15.1.330 List MA, Bulter P, Vokes M; et al. Head and neck cancer (HMC) patients: How do patients prioritize potential treatment outcomes? Program/Proceedings American Society of Clinical Oncology Thirty-Fourth Annual Meeting; 1998;17:382a. Kaanders, 1992, Accelerated fractionation radiotherapy for laryngeal cancer, acute, and late toxicity, Int J Radiat Oncol Biol Phys, 24, 497, 10.1016/0360-3016(92)91065-U Denham, 1996, Mucosal regeneration during radiotherapy, Radiother Oncol, 41, 109, 10.1016/S0167-8140(96)01830-0 Kaanders, 1995, Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer, Radiother Oncol, 37, 190, 10.1016/0167-8140(95)01660-0 Saunders, 1996, Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer, Br J Cancer, 73, 1455, 10.1038/bjc.1996.276 Lee, 1995, Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas [see comments], Int J Radiat Oncol Biol Phys, 32, 567, 10.1016/0360-3016(95)00150-W Fu KK. RTOG (90-03) A Phase III randomized study to compare twice daily hyperfractionation, accelerated hyperfractionation with concomitant boost to standard fractionation radiotherapy for squamous cell carcinomas of the head and neck, unpublished data. Philadelphia: RTOG Headquarters; 1993. Horiot, 1992, Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma, Radiother Oncol, 25, 231, 10.1016/0167-8140(92)90242-M Dische, 1997, A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer [see comments], Radiother Oncol, 44, 123, 10.1016/S0167-8140(97)00094-7 Horiot, 1997, Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers, Radiother Oncol, 44, 111, 10.1016/S0167-8140(97)00079-0 Maciejewski, 1996, Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer, Radiother Oncol, 40, 137, 10.1016/0167-8140(96)01776-8 Parsons, 1993, Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck, Head Neck, 15, 87, 10.1002/hed.2880150202 Ang, 1990, Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx, Int J Radiat Oncol Biol Phys, 19, 1339, 10.1016/0360-3016(90)90341-G Rubin P. RTOG (96-04)(LENT)Protocol to evaluate the late effects of normal tissue for head and neck cancer. Philadelphia; RTOG Headquarters; 1995. Jackson, 1997, A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer, Radiother Oncol, 43, 39, 10.1016/S0167-8140(97)01944-0 Taylor, 1994, Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer, J Clin Oncol, 12, 385, 10.1200/JCO.1994.12.2.385 Depondt, 1993, Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer, Oncology, 50, 23, 10.1159/000227257 Lefebvre, 1996, Larynx preservation in pyriform sinus cancer, J Natl Cancer Inst, 88, 890, 10.1093/jnci/88.13.890 Jaulerry, 1992, Induction chemotherapy in advanced head and neck tumors, Int J Radiat Oncol Biol Phys, 23, 483, 10.1016/0360-3016(92)90002-Y 1991, Department of Veterans Affairs Laryngeal Cancer Study Group, N Engl J Med, 324, 1685, 10.1056/NEJM199106133242402 Browman, 1994, Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer, J Clin Oncol, 12, 2648, 10.1200/JCO.1994.12.12.2648 Al-Sarraf, 1998, Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer, J Clin Oncol, 16, 1310, 10.1200/JCO.1998.16.4.1310 Haffty, 1997, Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck, Radiat Oncol Investig, 5, 235, 10.1002/(SICI)1520-6823(1997)5:5<235::AID-ROI4>3.0.CO;2-Z Haffty, 1997, Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck, J Clin Oncol, 15, 268, 10.1200/JCO.1997.15.1.268 Bachaud, 1996, Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma, Int J Radiat Oncol Biol Phys, 36, 999, 10.1016/S0360-3016(96)00430-0 Adelstein, 1993, Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer, J Clin Oncol, 11, 2136, 10.1200/JCO.1993.11.11.2136 Denham, 1991, Concurrent cisplatin, infusional fluorouracil, and conventionally fractionated radiation therapy in head and neck cancer, J Clin Oncol, 9, 458, 10.1200/JCO.1991.9.3.458 Cummings, 1986 Adelstein, 1997, A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer, Head Neck, 19, 567, 10.1002/(SICI)1097-0347(199710)19:7<567::AID-HED2>3.0.CO;2-5 Calais G, Alfonsi M, Bardet E. Randomized study comparing radiation alone (RT) versus RT with concomitant chemotherapy (CT) in stages III and IV oropharynx carcinoma (ARCORO). Proc Am Soc Clin Oncol 1998. Brizel, 1998, Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer, N Engl J Med, 338, 1798, 10.1056/NEJM199806183382503 Weichselbaum, 1982, Toxicity of aggressive multimodality therapy including cisplatinum, bleomycin and methotrexate with radiation and/or surgery for advanced head and neck cancer, Int J Radiat Oncol Biol Phys, 8, 909, 10.1016/0360-3016(82)90099-2 Benasso, 1995, Concomitant administration of two standard regimens of chemotherapy and radiotherapy in advanced squamous carcinoma of the head and neck, Anticancer Res, 15, 2651 Espinoza-Jacobs, 1995, Combined carboplatin plus bleomycin and conventional radiotherapy for advanced carcinomas of the head and neck, Am J Clin Oncol, 18, 52, 10.1097/00000421-199502000-00011 Sonis, 1998, Mucositis as a biological process, Oral Oncol, 34, 39, 10.1016/S1368-8375(97)00053-5 Peters, 1988, Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies, Acta Oncol, 27, 185, 10.3109/02841868809090339 Browman, 1993, The Head and Neck Radiotherapy Questionnaire, J Clin Oncol, 11, 863, 10.1200/JCO.1993.11.5.863 Sonis, 1999, Validation of a new scoring system for assessment of clinical trials research of oral mucositis induced by radiation or chemotherapy, Cancer, 85, 2103, 10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0 Parulekar, 1998, Scoring oral mucositis, Oral Oncol, 34, 63, 10.1016/S1368-8375(97)00065-1 Sanchiz, 1990, Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer, Int J Radiat Oncol Biol Phys, 19, 1347, 10.1016/0360-3016(90)90342-H Dobrowsky, 1998, Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer, Int J Radiat Oncol Biol Phys, 42, 803, 10.1016/S0360-3016(98)00321-6 Wendt, 1998, Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer, J Clin Oncol, 16, 1318, 10.1200/JCO.1998.16.4.1318 Keane, 1993, A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma, Int J Radiat Oncol Biol Phys, 25, 613, 10.1016/0360-3016(93)90006-H Pinto, 1991, Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma, Int J Radiat Oncol Biol Phys, 21, 557, 10.1016/0360-3016(91)90670-Y Fu, 1995, Late effects of hyperfractionated radiotherapy for advanced head and neck cancer, Int J Radiat Oncol Biol Phys, 32, 577, 10.1016/0360-3016(95)98061-C Bentzen, 1995, Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment... now! [editorial], Int J Radiat Oncol Biol Phys, 32, 1531, 10.1016/0360-3016(95)00262-W Cooper, 1995, Late effects of radiation therapy in the head and neck region, Int J Radiat Oncol Biol Phys, 31, 1141, 10.1016/0360-3016(94)00421-G Ang, 1997, Altered fractionation schedules, Principles Pract Radiat Oncol, 3, 1341 Nguyen, 1988, Analysis of late complications after rapid hyperfractionated radiotherapy in advanced head and neck cancers, Int J Radiat Oncol Biol Phys, 14, 23, 10.1016/0360-3016(88)90045-4 Parsons, 1995, Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx, Int J Radiat Oncol Biol Phys, 32, 605, 10.1016/0360-3016(95)00527-6 Lavertu, 1998, Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer, Arch Otolaryngol Head Neck Surg, 124, 401, 10.1001/archotol.124.4.401 Sassler, 1995, Surgery after organ preservation therapy, Arch Otolaryngol Head Neck Surg, 121, 162, 10.1001/archotol.1995.01890020024006 Girod, 1995, Risk factors for complications in clean-contaminated head and neck surgical procedures, Head Neck, 17, 7, 10.1002/hed.2880170103 Sarkar, 1990, Complications following surgery for cancer of the larynx and pyriform fossa, J Surg Oncol, 43, 245, 10.1002/jso.2930430411 Corey, 1986, Surgical complications in patients with head and neck cancer receiving chemotherapy, Arch Otolaryngol Head Neck Surg, 112, 437, 10.1001/archotol.1986.03780040077016 Fu, 1987, Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer, J Clin Oncol, 5, 1410, 10.1200/JCO.1987.5.9.1410 Dische, 1989, The recording of morbidity related to radiotherapy, Radiother Oncol, 16, 103, 10.1016/0167-8140(89)90026-1 Trotti, 1998, Development of a head and neck companion module for the quality of life–radiation therapy instrument (QOL-RTI), Int J Radiat Oncol Biol Phys, 42, 257, 10.1016/S0360-3016(98)00224-7 Bjordal, 1992, Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients, Acta Oncol, 31, 311, 10.3109/02841869209108178 Hassan, 1993, Assessment of quality of life in head and neck cancer patients, Head Neck, 15, 485, 10.1002/hed.2880150603 List, 1996, Longitudinal assessment of quality of life in laryngeal cancer patients, Head Neck, 18, 1, 10.1002/(SICI)1097-0347(199601/02)18:1<1::AID-HED1>3.0.CO;2-7 Terrell, 1997, Head and neck cancer-specific quality of life, Arch Otolaryngol Head Neck Surg, 123, 1125, 10.1001/archotol.1997.01900100101014 Giesler, 1998, Opportunities and challenges, J Natl Cancer Inst, 90, 1498, 10.1093/jnci/90.20.1498 de Boer, 1998, Disease-specific quality of life, Qual Life Res, 7, 135, 10.1023/A:1008805409794 McDonough, 1996, Changes in quality-of-life scores in a population of patients treated for squamous cell carcinoma of the head and neck, Head Neck, 18, 487, 10.1002/(SICI)1097-0347(199611/12)18:6<487::AID-HED1>3.0.CO;2-Z Moore, 1996, Quality of life outcomes after primary radiotherapy for squamous cell carcinoma of the base of tongue, Int J Radiat Oncol Biol Phys, 36, 351, 10.1016/S0360-3016(96)00319-7 Deleyiannis, 1997, Quality of life of disease-free survivors of advanced (stage III or IV) oropharyngeal cancer, Head Neck, 19, 466, 10.1002/(SICI)1097-0347(199709)19:6<466::AID-HED2>3.0.CO;2-X Bentzen, 1997, Clinical manifestations of normal-tissue damage, 87 List, 1997, Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer, Qual Life Res, 6, 274, 10.1023/A:1026419023481 Harrison, 1997, Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue, Head Neck, 19, 169, 10.1002/(SICI)1097-0347(199705)19:3<169::AID-HED1>3.0.CO;2-0 Lazarus, 1996, Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy, Laryngoscope, 106, 1157, 10.1097/00005537-199609000-00021 Colangelo, 1996, T stage and functional outcome in oral and oropharyngeal cancer patients, Head Neck, 18, 259, 10.1002/(SICI)1097-0347(199605/06)18:3<259::AID-HED8>3.0.CO;2-Z Logemann, 1997, Super-supraglottic swallow in irradiated head and neck cancer patients, Head Neck, 19, 535, 10.1002/(SICI)1097-0347(199709)19:6<535::AID-HED11>3.0.CO;2-4 Pauloski, 1998, Surgical variables affecting speech in treated patients with oral and oropharyngeal cancer, Laryngoscope, 108, 908, 10.1097/00005537-199806000-00022